Biotech

All Articles

BioMarin stops preclinical gene therapy for heart disease

.After BioMarin conducted a springtime tidy of its pipeline in April, the business has made a decisi...

Eisai plants molecular adhesive SEED with $1.5 B biobucks deal

.Big Pharmas stay stuck to the tip of molecular glue degraders. The most up to date firm to observe ...

Life science credit history firm reveals with $600M

.A new global life science credit score organization, dubbed Symbiotic Funding, has actually raised ...

BMS channels TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another big wager coming from the Caforio age, ending an...

Nuvation stops BET prevention after thinking about phase 1 information

.After having a look at stage 1 record, Nuvation Biography has made a decision to halt focus on its ...

' Clinical intuition' led FDA experts to support Zevra's rare illness med

.Zevra Therapies' unusual illness drug seems to become on the road to confirmation this loss after g...

Pfizer takes $230M attacked after axing fell short DMD gene treatment

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has gone a $230 thousa...

AC Immune sees 'spots' prospective in Alzheimer's medicine records

.After more than 20 years of deal with neurodegenerative ailments, Swiss biotech a/c Invulnerable in...

GSK loses ph. 2 HPV vaccine over shortage of best-in-class prospective

.GSK has scrapped a period 2 human papillomavirus (HPV) vaccination from its own pipeline after deci...

OS Therapies refiles $6M IPO to money HER2 drug, preclinical ADCs

.Operating system Therapies will certainly specify on the NYSE American inventory substitution today...